A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).

NCT07732361 · clinicaltrials.gov ↗

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombotic Microangiopathy
Hematopoietic Stem Cell Transplant

Sponsor

Alexion Pharmaceuticals, Inc.